| Application no. and date | 18811407.8 (espacenet) (Federated) (European Patent Register), 20181031 | | Patent/reg. no. and date | DK/EP 3703658, 20220504 | | Publication date | 20200909 | | Priority no. and date | US 201762579671 P, 20171031 | | EP pub. no. and date |
EP 3703658 20200909 | | Effective date | | | Applicant/owner | ModernaTX, Inc., 200 Technology Square
Cambridge, MA 02139, US | | Applicant ref. no. | 1639310 | | Inventor | BENENATO, Kerry, 415 Lincoln Road
Sudbury
MA 01776, US,
HANSSON, Kenny, Mikael, AstraZeneca AB
SE-431 83 Mölndal, SE,
WÅGBERG, Maria, AstraZeneca AB
SE-431 83 Mölndal, SE,
PÅLSSON, Annika, AstraZeneca AB
SE-431 83 Mölndal, SE,
FRITSCHE-DANIELSON, Regina, AstraZeneca AB
SE-431 83 Mölndal, SE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/7088 (2006.01) , A61K 38/18 (2006.01) , A61K 48/00 (2006.01) , A61K 9/00 (2006.01) , A61K 9/127 (2006.01) | | Title | LIPIDNANOPARTIKLER TIL ADMINISTRATION AF MODIFICERET RNA, DER KODER FOR ET VEGF-A-POLYPEPTID | | Int. application no. | US2018058541 | | Int. publication no. | WO2019089818 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
